(Q47664388)

4 February 2018

title

Antennapedia transduction sequence promotes anti tumour immunity to epicutaneously administered CTL epitopes (English)

1 reference

4 February 2018

author name string

Marie-Paule M Schutze-Redelmeier

1

1 reference

4 February 2018

Spencer Kong

2

1 reference

4 February 2018

Marcel B Bally

3

1 reference

4 February 2018

Jan P Dutz

4

1 reference

4 February 2018

language of work or name

English

0 references

publication date

1 May 2004

1 reference

4 February 2018

published in

Vaccine

1 reference

4 February 2018

volume

22

1 reference

4 February 2018

issue

15-16

1 reference

4 February 2018

page(s)

1985-1991

1 reference

4 February 2018

Bone marrow-derived dendritic cells pulsed with synthetic tumour peptides elicit protective and therapeutic antitumour immunity

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Human dermal dendritic cells process and present soluble protein antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

The dendritic cell and human cancer vaccines

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Dendritic cells transduced with protein antigens induce cytotoxic lymphocytes and elicit antitumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Enhancement of antitumor immunity by prolonging antigen presentation on dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Dendritic cells and the control of immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Tumor antigen presentation by dermal antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Epidermal dendritic cells induce potent antigen-specific CTL-mediated immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Major histocompatibility complex class I-restricted CD8+ T cells and class II-restricted CD4+ T cells, respectively, mediate and regulate contact sensitivity to dinitrofluorobenzene

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Altered permeability and disordered cutaneous immunoregulatory function in mice with acute barrier disruption

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Conjugation of arginine oligomers to cyclosporin A facilitates topical delivery and inhibition of inflammation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

The design, synthesis, and evaluation of molecules that enable or enhance cellular uptake: peptoid molecular transporters

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Transloading of tumor antigen-derived peptides into antigen-presenting cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Efficient delivery of Antennapedia homeodomain fused to CTL epitope with liposomes into dendritic cells results in the activation of CD8+ T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Characterization of hybrid CTL epitope delivery systems consisting of the Antennapedia homeodomain peptide vector formulated in liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Class I-restricted processing and presentation of exogenous cell-associated antigen in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Exact prediction of a natural T cell epitope

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

CpG-DNA activates in vivo T cell epitope presenting dendritic cells to trigger protective antiviral cytotoxic T cell responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Skin immunization made possible by cholera toxin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Cholera toxin induces maturation of human dendritic cells and licences them for Th2 priming

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Fusogenic liposomes efficiently deliver exogenous antigen through the cytoplasm into the MHC class I processing pathway

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

DNA activates human immune cells through a CpG sequence-dependent manner

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Bacterial CpG-DNA triggers activation and maturation of human CD11c-, CD123+ dendritic cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

Divergent therapeutic and immunologic effects of oligodeoxynucleotides with distinct CpG motifs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2003.10.028

10.1016/J.VACCINE.2003.10.028

7 January 2021

Identifiers

DOI

1 reference

4 February 2018

1 reference

4 February 2018